Vaccination News Home Page

http://bmj.com/cgi/content/abstract/325/7357/188

BMJ
 

Home Help Search/Archive Feedback Table of Contents

Abridged text of this article
PDF [abridged] of this article
Full text of this article
PDF of this article
Email this article to a friend
Respond to this article
Read responses to this article
See related This week in BMJ item
Related editorials in BMJ
PubMed citation
Related articles in PubMed
Download to Citation Manager
Search Medline for articles by:
Fichtenberg, C. M || Glantz, S. A
Alert me when:
New articles cite this article
 
Collections under which this article appears:
Environmental Issues
Occupational Health
Systematic reviews (incl meta-analyses): examples
Other respiratory medicine
Drugs: infections
International health

BMJ 2002;325:188 ( 27 July )
 

Papers

Effect of smoke-free workplaces on smoking behaviour: systematic review

Caroline M Fichtenberg, research fellowStanton A Glantz, professor of medicine

Center for Tobacco Control Research and Education, Institute for Health Policy Studies, Cardiovascular Research Institute, University of California, San Francisco, San Francisco, CA 94143, USA

Correspondence to: S A Glantz glantz@medicine.ucsf.edu

Objective: To quantify the effects of smoke-free workplaces on smoking in employees and compare these effects to those achieved through tax increases.
Design: Systematic review with a random effects meta-analysis.
Study selection: 26 studies on the effects of smoke-free workplaces.
Setting: Workplaces in the United States, Australia, Canada, and Germany.
Participants: Employees in unrestricted and totally smoke-free workplaces.
Main outcome measures: Daily cigarette consumption (per smoker and per employee) and smoking prevalence.
Results: Totally smoke-free workplaces are associated with reductions in prevalence of smoking of 3.8% (95% confidence interval 2.8% to 4.7%) and 3.1 (2.4 to 3.8) fewer cigarettes smoked per day per continuing smoker. Combination of the effects of reduced prevalence and lower consumption per continuing smoker yields a mean reduction of 1.3 cigarettes per day per employee, which corresponds to a relative reduction of 29%. To achieve similar reductions the tax on a pack of cigarettes would have to increase from $0.76 to $3.05 (0.78 to 3.14) in the United States and from £3.44 to £6.59 (5.32 to 10.20) in the United Kingdom. If all workplaces became smoke-free, consumption per capita in the entire population would drop by 4.5% in the United States and 7.6% in the United Kingdom, costing the tobacco industry $1.7 billion and £310 million annually in lost sales. To achieve similar reductions tax per pack would have to increase to $1.11 and £4.26.
Conclusions: Smoke-free workplaces not only protect non-smokers from the dangers of passive smoking, they also encourage smokers to quit or to reduce consumption.

 

What is already known on this topic
Smoke-free workplaces are associated with lower cigarette consumption per continuing smoker

What this study adds
Smoke-free workplaces reduce prevalence of smoking as well as consumption

The combined effects of people stopping smoking and reducing consumption reduces total cigarette consumption by 29%

To achieve similar results through taxation would require cigarette taxes per pack to increase from $0.76 to $3.05 in the United States and from £3.44 to £6.59 in the United Kingdom



 


 


© BMJ 2002

This article has been cited by other articles:

 

Rapid Responses:

Read all Rapid Responses

A Smoke-Free Womb Would be a Good Start
Tony Floyd
bmj.com, 26 Jul 2002 [Full text]
Can smoking bans be enforced?
Frank J Leavitt
bmj.com, 29 Jul 2002 [Full text]

Related editorials in BMJ:

Banning smoking in the workplace .
Robert West
BMJ 2002 325: 174-175. [Full text]  

 


 

 


Home Help Search/Archive Feedback Table of Contents

BMJ Intended for Health Professionals - Click here for further information
 

 

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.